Current Issue May 2012, Vol. 8, No. 4

Feature Article

In vivo tumor imaging using a novel RNAi-based detection mechanismFree

A new concept of tumor imaging is introduced using a siRNA-based probe that is capable of amplifying a specific endogenous fluorescence emission in cancerous tissue. In previous studies, we demonstrated a significant downregulation of Ferrochelatase (FECH) mRNA-expression in colorectal carcinomas leading to the accumulation of protoporphyrin IX (PpIX), a fluorescent metabolite of the heme synthesis.

Issue Highlights

  • Surface modification of PAMAM dendrimer improves its biocompatibility
    27 April 2012

    Michal Ciolkowski, Johannes F. Petersen, Mario Ficker, Anna Janaszewska, Jørn B. Christensen, Barbara Klajnert, Maria Bryszewska

  • Evaluation of SERS labeling of CD20 on CLL cells using optical microscopy and fluorescence flow cytometry
    27 April 2012

    Christina M. MacLaughlin, Edward P.K. Parker, Gilbert C. Walker, Chen Wang

  • Nanoparticles induce platelet activation in vitro through stimulation of canonical signalling pathways
    27 April 2012

    Gianni F. Guidetti, Alessandra Consonni, Lina Cipolla, Piercarlo Mustarelli, Cesare Balduini, Mauro Torti

  • Interaction of inorganic nanoparticles with the skin barrier: current status and critical review
    27 April 2012

    Hagar I. Labouta, Marc Schneider

  • Human serum albumin-coated lipid nanoparticles for delivery of siRNA to breast cancer
    27 April 2012

    Longzhu Piao, Hong Li, Lesheng Teng, Bryant C. Yung, Yasuro Sugimoto, Robert W. Brueggemeier, Robert J. Lee

  • View More Articles in Press...

On the Cover


Cover Image


About Nanomedicine: NBM

Nanomedicine: Nanotechnology, Biology and Medicine is an international, peer-reviewed journal. Each issue of Nanomedicine: NBM presents theoretical and experimental research results related to nanoscience and nanotechnology in life sciences, including Basic, Translational, and Clinical research, and commercialization of results. Article formats include Communications, Original Articles, Reviews, Perspectives, Technical and Commercialization Notes, Letters to the Editor, and Case Reports. In addition, regular features on our website will address commercialization, funding opportunities, and societal, Public Health, and ethical issues of nanomedicine. We invite authors to submit original manuscripts in these categories.

More


Publishing Information

Nanomedicine: Nanotechnology, Biology and Medicine is published by Elsevier.

Access this journal onSciVerse ScienceDirect
Print or Share This Page

Journal Metrics

Impact Factor

Nanomedicine: NBM now ranks 13th of 63 journals in the Nanoscience and Nanotechnology subject category on the 2010 Journal Citation Reports®, published by Thomson Reuters.
Nanomedicine: NBM 2010 impact factor: 4.882
Nanomedicine: NBM 2010 Immediacy Index: 1.264

Journal Access

Full-text articles are available from 2005 to the present. Access to abstracts, editorials, perspectives, and feature articles is complimentary.

Activate Online Access

Nanomedicine: NBM News

Nanomedicine: NBM thanks its 2011 reviewers. The editorial team gratefully acknowledges its 2011 reviewers, and thanks them for their invaluable expertise and input. We especially thank those reviewers who completed 5 or more reviews in 2011.